MMP9 and liver dysplastic nodule: Rysz et al. measured the circulating levels of MMP2, MMP9 and their inhibitors (TIMP1 and TIMP2) in T2D patients with or without DN, in patients with non-diabetic chronic renal failure (CRF), and in healthy controls [207].